In order to ensure the best market practices, combined with improvements to corporate governance, the company has an area dedicated to Corporate Integrity, which encompasses Compliance, Risk Management and Internal Audit. It reports directly to the Ethics Committee, which is directly linked to the company’s presidency.

Click here and check out our Annual Compliance Report.

Annual Compliance Report (base year 2023)

The Ethics Committee is responsible for receiving occurrences from the various communication channels, conducting analyses and appropriately forwarding the facts. It holds weekly meetings, which confirms the major importance of this issue at Eurofarma.

The Corporate Integrity area reports to this committee, which discusses the seriousness of the occurrences and actions to be taken to mitigate the associated risks.

The results of internal audits are also presented and discussed to better address the actions. This body also observes whether the areas are acting according to the recommended implementations.

Ethics and Conduct

This publication expresses our Values, Mission and Objectives, which will be achieved from an ethical and transparent position. It summarizes the daily attitudes and behaviors that the company expects from each employee when dealing with colleagues, staff, suppliers, customers, the community and society. All employees, including international operations, receive specific training on the Code of Ethics and Conduct, which must be followed by everyone in the company and also serves as a reference for business partners.

Click here to read the Code of Ethics and Conduct in its entirety, understand and use this document as a reference in daily contact with Eurofarma.

Supplier Code of Ethics and Conduct

The Supplier Code of Ethics and Conduct establishes guidelines that must be followed by suppliers to ensure that their actions are in accordance with company values. The Code assists competent areas in conducting audits and contributes to ensuring that partners follow good organizational practices as well.

Eurofarma believes this is the best way to maintain ethical and sustainable relations.

Key topics of the Code:

• Labor Rights
• Health and Safety
• Socio-environmental Responsibility
• Business Integrity
• Confidentiality of Intellectual Property

Click here to access the Supplier Code of Ethics and Conduct.

The purpose of our Board of Directors is to support and evaluate the company’s strategic decisions. It is comprised of independent business leaders with varied backgrounds, enabling them to provide the company an unbiased, objective and rational view of the business.

In addition to the company’s president, the committee consists of six independent members who meet monthly.

Claudio Roberto Ely
A Civil Engineer who graduated from Universidade Federal do Rio Grande do Sul, he has over 40 years of experience in leading major organizations. He was in charge of companies in the hydroelectric and financial sectors and has extensive experience in the retail pharmaceutical industry.

Cristina Palmaka

In 2019, Cristina assumed the Presidency of SAP for Latin America and the Caribbean. From 2013 to 2019, she served as president of SAP Brasil, one of the most important subsidiaries of the global company. Cristina has extensive professional experience focusing on innovation and technologies in the Brazilian IT industry. She acts as a corporate governance agent, ensuring its proper functioning, aiming at achieving growth in sustainability and collaborating with the Board for its future decisions. Cristina promotes equality and diversity in the corporate environment, articulating strong integration between teams.

Juliana Rozenbaum
Juliana has a degree in Economics and the CFA® designation, in addition to extensive experience in the consumer and retail sector. She is a member of the Board of Directors for Lojas Renner and Arezzo&Co, and an independent member of the Board of Directors for Duratex S.A. and EDP, Energias do Brasil S.A. She also participates in several Committees within these companies. In addition to Eurofarma, she is an advisory board member for GoCase and Uatt – Endeavor entrepreneurial companies.

Marcelo Martins
Marcelo Martins has been Vice President of Finance and Investor Relations at Cosan Limited since April 2015. With a bachelor’s in Business Administration from Fundação Getúlio Vargas (FGV) and specializing in finance, Martins is a member of the Board of Directors for Cosan Limited, Cosan S.A, Rumo ALL, Comgás, Cosan Logística, Rumo Logística and Radar. He also participates in the Boards for Fundação Bienal, MASP and the Museu Reina Sofia in Madrid. He joined Cosan in July 2007 as an executive of Aguassanta Participações S.A. and was Vice President of Finance and Investor Relations for Cosan S.A from 2009 to 2015. Prior to working for Cosan, he was Financial and Business Development Officer for Votorantim Cimentos from 2003 to 2007. He also headed the Latin American Fixed Income department for Salomon Smith Barney in New York.

Nelson Mussolini
Nelson is an attorney with over 30 years of experience in the pharmaceutical industry. His experience goes beyond the legal field, including finance and HR. He has already participated in merger processes and always maintained the activity along with the class associations. He is currently executive president of Sindusfarma – Industry Syndicate of Pharmaceutical Products in the State of São Paulo.

Julio Cesar Gagliardi

Julio Cesar Gagliardi entered Eurofarma in 2001, assuming the Commercial area. Since 2008 he acted as the Vice President of the Commercial area, commanding the business units of Medical Prescription, Generics, Oncology, Hospital and Bids. In July of 2023, Mr. Julio is no longer an employee of Eurofarma and is now a consultant and a member for Eurofarma's Board of Directors.

The Ombudsman is a direct, independent and confidential communication channel where employees, customers and suppliers can report suspicious episodes, facts and behavior that are in disagreement with the company’s Code of Ethics and Conduct.

Contact can be made anonymously over the phone and the Internet. Each report received generates a sequential registration number, which allows the person filing the report to track the progress of the process. The report is presented and discussed in the Ethics Committee by the Corporate Integrity area, which has 30 days for evaluation, investigation and response, and this period may be postponed for an equal period if necessary.

The Ombudsman contributes to mitigating the company’s risks. It is a tool that provides confidentiality, anonymity and discretion when conducting investigations in order to reduce the impacts of meaningless reports and focus on the issues applicable to them.

The reports are constantly evaluated in order to reinforce the correct use of the Ombudsman. The report can be made through our Ombudsman's own website, or through the exclusive telephone line for each country:

Argentina: 0800-345-3145
Bolivia: 800-104 612
Brazil: 0800-6021834
Chile: 800 914 489
Colombia: 01-800-5189605
Costa Rica: 8000320029
El Salvador: 8006414
Ecuador: 1800 001 131
Guatemala: 1800 300 0189
Honduras: 80027916003
Mexico: 800 681 8206
Nicaragua: 18002202475
Panama: 8002030093
Paraguay: 9800120003
Peru: (0800) 78148
Dominican Republic: 1 (809) 200-1590
Uruguay: 000 416 205 2735

Eurofarma conducts its business according to the highest ethical and moral standards set out in its Code of Ethics and Conduct, not tolerating any form of corruption and bribery. We are committed to conducting our operations in strict compliance with all applicable laws, including anti-corruption legislation (including Law 12.846/13) and other standards governing our relationship with public and private administration.

In 2017, the Code of Ethics and Conduct was updated with specific policies on Fighting Corruption and Healthcare Professional Relationships, as required by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) Code and Interfarma Code of Conduct. Regulated terms include sponsorship of professionals and events and free sample distribution.

The Anti-Corruption Policy lists the guidelines, standards and procedures that aim to ensure that Eurofarma – and all those acting on its behalf – understand and act in accordance with applicable anti-corruption laws in all dealings with public administration or public officials, as well as in dealings with the private sector.

Click here to see the full document (in portuguese).